CRVS Financials

Corvus Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$14.27

Market Cap

$1.04B

P/E Ratio

-14.0

EPS

$-0.54

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-62.29M

EPS (Diluted)

$-1.02

Balance Sheet Highlights

Total Assets

$68.91M

Total Liabilities

$36.34M

Shareholders Equity

Cash & Equivalents

$8.74M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-25.42M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-35.8%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CRVS revenue?

View CRVS's income statement for detailed revenue data.

Is CRVS profitable?

CRVS reported a loss of $62.29M in the most recent quarter.

What is CRVS market cap?

CRVS has a market capitalization of $1.04B, making it a small-cap stock.

Does CRVS have debt?

View CRVS's balance sheet for debt information.

What is CRVS cash flow?

Cash flow data is available in the full financial statements.